Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
3
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
HLS Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Price Controls And Generics Will Erode Future Margins
Key Takeaways Upcoming patent expiries and growing generic competition threaten HLS's ability to sustain premium pricing, top-line sales, and long-term financial stability. Overreliance on a limited product range and lack of early-stage pipeline heighten the risk of volatile earnings and revenue contraction.
View narrative
CA$3.86
FV
31.5% overvalued
intrinsic discount
4.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ModivCare
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Medicare Reimbursement Cuts And Digital Rivals Will Weaken Revenues
Key Takeaways Heavy reliance on government payers and traditional fee-for-service models exposes ModivCare to significant regulatory, reimbursement, and modernization risks, jeopardizing top-line growth and market viability. Digital disruption, operational inefficiencies, and balance sheet pressures undermine prospects for sustainable earnings improvement and raise concerns about long-term financial stability.
View narrative
US$1.20
FV
95.8% overvalued
intrinsic discount
0.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
FAT Brands
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Rising Debt And Costs Will Threaten Margins Yet Enable Turnaround
Key Takeaways High debt and cost pressures constrain profitability and reinvestment, while evolving consumer preferences and operational risks threaten future growth. Ambitious expansion and digital gains are challenged by labor shortages, supply chain disruption, and franchisee vulnerabilities.
View narrative
US$10.00
FV
80.3% undervalued
intrinsic discount
4.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
CareRx
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Canadian Healthcare Cost Cuts Will Crush Margins In Future
Key Takeaways Government cost containment and demographic trends are pressuring CareRx's margins and threatening to shrink its core market and future revenue stability. Dependence on a few large contracts and slow geographic diversification exposes CareRx to client and regional risks, limiting its growth potential.
View narrative
CA$2.25
FV
33.8% overvalued
intrinsic discount
3.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Transgene
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
High-Risk Clinical Trials And Rising Costs Will Delay Returns Yet Unlock Value
Key Takeaways Reliance on early-stage pipeline, extended clinical timelines, and delayed revenue risk are compounded by heavy R&D spending and ongoing losses without approved products. Competitive pressures, regulatory challenges, and dependence on external partnerships create uncertainty around commercialization prospects, long-term profitability, and future funding stability.
View narrative
€1.40
FV
27.1% undervalued
intrinsic discount
7.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Red Robin Gourmet Burgers
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Burger Dependence And Rising Labor Costs Will Exacerbate Decline
Key Takeaways Shifting consumer preferences and increased competition from tech-savvy brands threaten traffic, sales, and long-term relevance due to limited differentiation and slow digital adaptation. Ongoing cost pressures from labor, commodities, and supply chain risk eroding profit margins as operational efficiency gains struggle to offset inflation, challenging sustained profitability.
View narrative
US$6.00
FV
12.0% overvalued
intrinsic discount
-3.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
PRPL
Purple Innovation
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Amazon And Walmart Rivalry Will Undermine Long-Term Prospects
Key Takeaways Rising competition, shifting consumer preferences, and regulatory pressures threaten Purple's ability to defend market share and sustain long-term growth. Continued reliance on high marketing spend and a limited product lineup exposes Purple to profitability risks amid changing industry dynamics.
View narrative
US$1.00
FV
12.0% overvalued
intrinsic discount
9.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
908 Devices
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
US And NATO Shifts Will Cripple Demand But Open Opportunities
Key Takeaways Heavy reliance on government budgets and limited product platforms creates revenue risks amid uncertain policy shifts and technological change. Slower product adoption, ongoing regulatory pressures, and competitive innovation may hinder margin expansion and consistent long-term growth.
View narrative
US$8.00
FV
17.1% undervalued
intrinsic discount
7.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Veritone
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Concentrated Customers And AI Margin Pressure Will Yield Cautious Recovery
Key Takeaways Heavy dependence on a few major customers and financial fragility threaten Veritone's revenue stability, margin improvement, and ability to fund future growth. Rising AI commoditization, regulatory compliance costs, and macroeconomic pressures could erode pricing power and hinder the company's expansion in high-growth markets.
View narrative
US$3.00
FV
12.3% undervalued
intrinsic discount
16.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies